Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in the in Oculo Grafting Model

Experimental Neurology

Volumn 148, Issue 1, 1997, Pages 324-333

  Björklund, Lars ^a   Spenger, Christian ^a   Strömberg, Ingrid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DOPAMINE; PREGNANE DERIVATIVE; TIRILAZAD;

ANIMAL; ANTERIOR EYE CHAMBER; ARTICLE; BRAIN TRANSPLANTATION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HETEROTOPIC TRANSPLANTATION; MESENCEPHALON; NERVE CELL; NERVE FIBER; PARKINSON DISEASE; PRENATAL DEVELOPMENT; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION; ULTRASTRUCTURE;

ANIMALS; ANTERIOR CHAMBER; ANTIOXIDANTS; BRAIN TISSUE TRANSPLANTATION; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; MESENCEPHALON; NERVE FIBERS; NEURONS; PARKINSON DISEASE; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROTOPIC;

EID: 0031266085     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6655     Document Type: Article

References (63)

1. Abercrombie, M. 1946. Estimation of nuclear population from microtome sections. Anat. Rec. 94: 239-247.
2. Andersson, D. K., J. M. Braughler, and E. D. Hall. 1988. Effects of treatment with U-74006F on neurological recovery following experimental spinal cord injury. J. Neurosurg. 69: 562-567.
3. Arbuthnott, G., S. Dunnett, and N. MacLeod. 1985. Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain. Neurosci. Lett. 57: 205-210.
4. Beck, K. D., B. Knüsel, and F. Hefti. 1993. The nature of trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52: 855-866.
5. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
6. Björklund, A., and U. Stenevi. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177: 555-560.
7. Bolam, J. P., T. F. Freund, A. Björklund, S. B. Dunnett, and A. D. Smith. 1987. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host striatum. Exp. Brain Res. 68: 131-146.
8. Braughler, J. M., and E. D. Hall. 1989. Central nervous system trauma and stroke. I. Biochemical consideration for oxygen radical formation and lipid peroxidation. Free Rad. Biol. Med. 6: 289-301.
9. Brundin, P., O. Nilsson, R. Strecker, O. Lindvall, B. Astedt, and A. Björklund. 1986. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65: 235-240.
10. Brundin, P., R. Strecker, H. Widner, D. Clarke, O. Nilsson, B. Åstedt, O. Lindvall, and A. Björklund. 1988. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70: 192-208.
11. Clarke, D., P. Brundin, R. Strecker, O. Nilsson, A. Björklund, and O. Lindvall. 1988. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultratructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73: 115-126.
12. Clarke, W. M., S. Hazel, and B. M. Coull. 1995. Lazaroids: CNS pharmacology and current research. Drugs 6: 971-985.
13. Clarkson, E. D., W. M. Zawada, and C. R. Freed. 1995. GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport 7: 145-149.
14. Date, I., M. Notter, S. Felten, and D. Felten. 1990. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526: 156-160.
15. Ebendal, T., L. Olson, Å. Seiger, and K-O. Hedlund. 1980. Nerve growth factors in the rat iris. Nature 286: 25-28.
16. Ebendal, T., I. Strömberg, L. Olson, and Å. Seger. 1985. Parasympathetic neurotrophic activity in the rat iris: determination after different denervation. Neuroscience 16: 181-185.
17. Fisher, L. J., S. J. Young, J. M. Tepper, P. M. Groves, and F. H. Gage. 1991. Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience 40: 109-122.
18. Freund, T. F., J. P. Bolam, A. Björklund, U. Stenevi, S. B. Dunnett, J. F. Powell, and A. D. Smith. 1985. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: A tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5: 603-616.
19. Frodl, E. M., N. Nakao, and P. Brundin. 1994. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurons. NeuroReport 5: 2393-2396.
20. Gerfen, C. R., K. G. Baimbridge, and J. Thibault. 1987. The neostriatal mosaic. III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 7: 3935-3944.
21. Gerfen, C. R., M. Herkenham, and J. Thibault. 1987. The neostriatal mosaic. II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7: 3915-3034.
22. Giacobini, M. M. J., I. Strömberg, S. Almström, Y. Cao, and L. Olson. 1993. Fibroblast growth factors enhance dopamine fiber formation from nigral grafts. Dev. Brain Res. 75: 65-73.
23. Hall, E., J. M. McCall, and E. D. Means. 1994. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrage. Adv. Pharmacol. 28: 221-268.
24. Hall, E. D., and J. M. Braughler. 1989. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Rad. Biol. Med. 6: 303-313.
25. Hall, E. D., P. A. Yonkers, J. M. McAll et al. 1988. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J. Neurosurg. 68: 456-461.
26. Halliway, B., and M. C. Gutteridge. 1990. Role of free radicals and catalytic metal ions in human disease: An overview. In Methods in Enzymology (L. Packer and A. N. Glazer, Eds), pp 1-85. Academic Press, San Diego.
27. Hyman, C., M. Hofer, Y.-A. Barde, M. Juhasz, G. Jancopoulos, S. Squinto, and R. Lindsay. 1991. BNDF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232.
28. Hyman, C., M. Juhasz, C. Jackson, P. Wright, N. Y. Ip, and R. M. Lindsay. 1994. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14: 335-347.
29. Hynes, M. A., K. Poulsen, M. Armanini, L. Berkemeier, H. Phillips, and A. Rosenthal. 1994. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37: 144-154.
30. Jaeger, C. B. 1985. Cytoarchitectonics of substantia nigra grafts: A light- and electronmicroscopic study of immunocytochemically identified dopaminergic neurons and fibrous astrocytes. J. Comp. Neurol. 231: 121-135.
31. Johansson, M., M. Friedemann, B. Hoffer, and I. Strömberg. 1995. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134: 25-34.
32. Johnson, D., and G. de C Nogueira-Araujo. 1981. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43: 349-350.
33. Knüsel, B., J. Winslow, A. Rosenthal, L. Burton, B. Seid, K. Nikolicks, and F. Hefti. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA 88: 961-965.
34. Kordower, J. H., T. B. Freeman, B. J. Snow, F. J. G. Vingerhoets, E. J. Mufson, P. R. Sandberg, R. A. Hauser, D. A. Smith, G. M. Nauert, D. P. Perl, and C. W. Olanow. 1995. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124.
35. Lin, L.-F. H., D. H. Doherty, J. D. Lile, S. Bektesh, and F. Collins. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
36. Lindvall, O., S. Rehncrona, B. Gustaavii, P. Brundin, B. Astedt, H. Widner, T. Lindholm, A. Björklund, K. Leenders, J. Rothwell, R. Frackowiak, C. D. Marsden, B. Johnels, G. Steg, R. Freedman, B. J. Hoffer, Å. Seiger, I. Strömberg, M. Bygdeman, and L. Olson. 1988. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 8626-8267: 1483-1484.
37. Mahalik, T. J., T. E. Finger, I. Strömberg, and L. Olson. 1985. Substantia nigra transplants into denervated striatum of the rat: Ultrastructure of graft and host interconnections. J. Comp. Neurol. 260: 60-70.
38. Mahalik, T. J., W. E. Hahn, G. H. Clayton, and G. P. Owens. 1994. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129: 27-36.
39. McIntosh, T. K., M. Thomas, and D. Smith. 1992. The novel 21-aminosteroid U74006F attenuates cerebral edema in a proved survival after head injury in the rat. J. Neurotrauma 9: 33-46.
40. Nakao, N., E. M. Frodl, W.-M. Duan, H. Widner, and P. Brundin. 1994. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91: 12408-12412.
41. Olanow, C. W. 1992. An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 32(suppl.): S2-S9.
42. Olson, L., Å. Seiger, and I. Strömberg. 1983. Intraocular transplantation in rodents: A detailed account of the procedure and examples of its use in neurobiology with special reference to brain tissue grafting. In Advances in Cellular Neurobiology (S. Federoff and L. Hertz, Eds.), Vol. 4, pp. 407-442. Academic Press, New York.
43. Otto, D., and K. Unsicker. 1990. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10: 1912-1921.
44. Perlow, M. J., W. J. Freed, B. J. Hoffer, À. Seiger, L. Olson, and R. J. Wyatt. 1979. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204: 643-647.
45. Rehncrona, S. 1997. A critical review of the current status and possible developments in brain transplantation. In Advances and Technical Standards in Neurosurgery (F. Cohadon, V. V. Dolene, I. Lobo Auntes, H. Nornes, J. D. Pickard, H.-J. Reulen, A. J. Strong, N. deTribolet, and C. A. F. Tulleken, Eds.), pp 3-46. Springer-Verlag, Wien.
46. Rose, G., G. Gerhardt, I. Strömberg, L. Olson, and B. Hoffer. 1985. Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: An in vivo electrochemical study. Brain Res. 341: 92-100.
47. Sanada, T., T. Nakamure, and M. E. A. Nishimura. 1993. Effects of U74006F on neurological function and brain edema after fluid percussion injury in rats. J. Neurotrauma 10: 65-71.
48. Sincair, S. R., C. N. Svendsen, E. M. Torrs, D. Martin, J. W. Fawcett, and S. B. Dunnett. 1996. GDNF enhances cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport 7: 2547-2552.
49. Spenger, C., C. Hyman, L. Studer, M. Egli, L. Evtouchenko, C. Jackson, A. Dahl-Jorgensen, R. M. Lindsay, and R. W. Seiler. 1995. BDNF augments phenotype expression of dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp. Neurol. 133: 50-63.
50. Strömberg, I., P. Almqvist, M. Bygdeman, T. Finger, G. Gerhardt, A.-C. Granholm, T. Mahalik, A. Seiger, B. Hoffer, and L. Olson. 1988. Intracerebral xenografts of human mesencephalic tissue into athymic rats: Histochemical and in vivo electrochemical studies. Proc. Natl. Acad. Sci. USA 85: 8331-8434.
51. Strömberg, I., L. Björklund, and P. Förander. 1997. The age of striatum determines the pattern and extent of dopaminergic innervation: A nigrostriatal double graft study. Cell Transplant. 6: 287-296.
52. Strömberg, I., L. Björklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. Hoffer, and C. Humpel. 1993. Glial cell-derived neurotrophic factor (GDNF) is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124: 401-412.
53. Strömberg, I., M. Bygdeman, M. Goldstein, A. Seiger, and L. Olson. 1986. Human fetal substantia nigra grafted to the dopamine-deneervated striatum of immunosuppressed rats: Evidence for functional reinnervation. Neurosci. Lett. 71: 271-276.
54. Strömberg, I., C. van Home, M. Bygdeman, N. Weiner, and G. Gerhardt. 1991. Function of intraventricular human mesencephalic xenograft in immunosuppressed rats: An electrophysiological and neurochemical analysis. Exp. Neurol. 112: 140-152.
55. Studer, L., C. Spenger, R. W. Seiler, C. A. Altar, R. M. Lindsay, and C. Hyman. 1995. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7: 223-233.
56. Taylor, B. M., W. E. Fleming, C. W. Benjamin, Y. Wu, W. R. Mathews, and F. F. Sun. 1996. The mechanism of cytoprotective action of lazaroids. I. Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J. Pharm. Exp. Ther. 276: 1224-1231.
57. Tepper, J. M., M. Damlama, and F. Trent. 1994. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 60: 469-477.
58. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
59. Tomac, A., E. Lindqvist, L.-F. Lin, S. O. Ögren, D. Young, B. J. Hoffer, and L. Olson. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339.
60. Trulson, M. E., and A. Hosseini. 1987. Dopamine neuron transplants: Electrophysiological unit activity of intrastriatal nigral grafts in freely moving cats. Life Sci. 40: 2097-2102.
61. Van Horne, C., T. Mahalik, B. Hoffer, M. Bygdeman, P. Almqvist, P. Stieg, Å. Seiger, L. Olson, and I. Strömberg. 1990. Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum. Brain Res. Bull. 25: 325-334.
62. Wuerthele, S., W. Freed, L. Olson, J. Morihisa, L. Spoor, R. Wyatt, and B. Hoffer. 1981. Effects of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat. Exp. Brain Res. 44: 1-10.
63. Zetterström, T., P. Brundin, F. G. Gage, T. Sharper, O. Isacson, S. B. Dunnett, U. Ungerstedt, and A. Björklund. 1986. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res. 362: 344-349.